Equity Analysis /
United States of America

US : Harmony Biosciences Holdings, Inc. - HRMY | Initiating at Outperform: Solid Outlook in Narcolespy; Upside Drivers On the Horizon in 2022

    Danielle Brill
    CGS-CIMB
    3 November 2021
    Published by